Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RF16001 for Analgesia After Total Hip Arthroplasty
NCT07872826Phase 3Enrolling by invitation
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 3 trial of RF16001 in postoperative pain, sponsored by Third Xiangya Hospital, Central South University. Started Oct 2026; status: enrolling by invitation.
02
Drugs
RF16001
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07872826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07872826.